Press Releases

Alfa Chemistry Rolls Out Various Nucleic Acid Delivery Options for Nucleotide Vaccine Research

REVIAN Inc.'s plans for a second study of the Revian Red Hair Growth System to evaluate its efficacy as a treatment option for Central Centrifugal Cicatricial Alopecia ("CCCA")

Clinical studies have shown that minoxidil can effectively promote hair regrowth in individuals with alopecia areata, particularly in mild to moderate hair loss cases. Results may vary from person to person, and not everyone may respond to minoxidil treatment. To see the best results, it's also essential to use minoxidil consistently and as directed. This means applying it regularly to the affected areas of the scalp and continuing treatment even after hair regrowth occurs to maintain results.

Firstsource Acquires Quintessence

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI

Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of AI-powered pathology technology, have joined forces to accelerate digital and AI pathology innovations. This collaboration aims to enhance the quality, speed, and efficiency of diagnosing cancer and other diseases, marking a monumental advancement in medical diagnostics.

ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024

ELRIG UK announced the keynote speakers for its flagship conference, Drug Discovery 2024: Ijeoma Uchegbu FMedSci, Professor of Pharmaceutical Nanoscience at University College London (UCL) and Chief Scientific Officer (CSO) at Nanomerics, and Marcus Schindler PhD, CSO and Executive Vice President of Research and Early Development at Novo Nordisk.

CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’

Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025

Watson-Marlow advances its OEM panel mount solution DriveSure with latest technology

Watson-Marlow Fluid Technology Solutions (WMFTS) has advanced DriveSure® with the latest technology to offer a complete peristaltic panel mount pump solution for original equipment manufacturers (OEMs).

Hoag Health System Selects PathAI and the AISight Image Management System to Support the Transition To Digital and AI-enabled Pathology

PathAI, a leading precision pathology company, today announced that Hoag Health System, the leading health system in the southern California region, will adopt the AISight Image Management System (IMS) as their primary platform, powering their transition to digital pathology. The transition from analog, glass-slide-based pathology to digital pathology continues to accelerate across anatomic pathology, globally. This transition is in part driven by the availability of AI pathology tools that harness machine learning (ML) algorithms to augment and assist the pathologist interpretation.

Using AI to Improve Diagnosis of Rare Genetic Disorders

Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process more efficient using artificial intelligence. The team developed a machine learning system called AI-MARRVEL (AIM) to help prioritize potentially causative variants for Mendelian disorders. The study is published today in NEJM AI. Researchers from the Baylor Genetics clinical diagnostic laboratory noted that AIM's module can contribute to predictions independent of clinical knowledge of the gene of interest, helping to advance the discovery of novel disease mechanisms.

SpecialtyVETPATH Taps Proscia For A Full Transformation Of Its Pathology Operations

Advancing diagnosis and research with an enterprise software platform

Clarapath Forms Strategic Collaboration with Mayo Clinic to Advance Pathology Tissue Processing

Clarapath forms strategic collaboration with Mayo Clinic to advance pathology tissue processing. Robotics, AI, and automation help improve patient outcomes and solve laboratory labor shortages

Cyclo Therapeutics, Inc. Announced the Start of its Phase 2b Study for Trappsol Cyclo to Treat Alzheimer's Disease, Aiming to Reduce Amyloid Beta and Tau

Scientists are always looking for ways to develop better medications or other therapies that can help slow down the progression of the disease or improve symptoms. This might involve testing new drugs in the lab or in clinical trials with people who have Alzheimer's.

Alfa Cytology Launches Full-Scale Research Services for Pancreatic Cancer to Achieve Preclinical Safety Assessment

Alfa Cytology has announced its pancreatic cancer research services for anticancer therapy in early preclinical stages.

Alfa Cytology Introduces Molecular Biology Services for TME Research

Alfa Cytology has announced its molecular biology services for TME research.

Sakura Finetek Europe BV welcomes Mr Jaap Stuut as its President and General Manager

Sakura Finetek Europe announces the appointment of Jaap Stuut as the President and General Manager.

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

PathAI Partners with Google Cloud to Transform Drug Discovery and Precision Medicine Through AI-Powered Pathology

PathAI, a global leader in AI-powered pathology, today announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology (AP) labs accelerate the adoption of AI and digital pathology.

ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery

The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, today entered into a partnership with SRG, leaders in life science recruitment, to support the advancement of science professionals in their careers.

Ace Neuroscience Unveils Integrated Drug Development Services for Stroke

Ace Neuroscience announces the launch of its integrated drug development services specifically designed for preclinical research on stroke.

Watson-Marlow Fluid Technology Solutions launches WMArchitect single-use solutions to optimise biopharmaceutical fluid management

Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitectTM single-use solutions to offer a wide range of biopharmaceutical fluid management innovations from a single, secure supplier.